Our diverse portfolio of products and product candidates spans a wide range of therapeutic indications and dosage forms. With a special focus on cardiovascular products, we endeavour to improve hospital care for patients who have critical cardiovascular indications. We also further develop and improve already-approved pharmaceuticals and established products, creating new and different solutions.

Disclaimer: Estimated timeline/indication in the pipeline is subject to changes in development plans and regulatory
requirements/clarifications, including complementary /additional studies